Free Trial

Short Interest in Option Care Health, Inc. (NASDAQ:OPCH) Decreases By 34.8%

Option Care Health logo with Medical background

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 3,800,000 shares, a decrease of 34.8% from the December 15th total of 5,830,000 shares. Approximately 2.3% of the company's stock are sold short. Based on an average daily trading volume, of 2,120,000 shares, the short-interest ratio is currently 1.8 days.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Barrington Research increased their price target on Option Care Health from $32.00 to $33.00 and gave the stock an "outperform" rating in a research note on Tuesday. The Goldman Sachs Group downgraded Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and lowered their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $29.86.

Read Our Latest Research Report on Option Care Health

Option Care Health Trading Up 2.6 %

OPCH stock traded up $0.71 during midday trading on Tuesday, hitting $28.43. The company had a trading volume of 1,566,361 shares, compared to its average volume of 2,038,327. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The stock has a market cap of $4.84 billion, a price-to-earnings ratio of 23.89, a PEG ratio of 2.43 and a beta of 1.31. The stock's 50 day moving average price is $23.20 and its 200 day moving average price is $27.69.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.64% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its holdings in shares of Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after acquiring an additional 1,328,326 shares during the period. FMR LLC raised its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP lifted its holdings in shares of Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after purchasing an additional 599,589 shares in the last quarter. State Street Corp grew its stake in shares of Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after acquiring an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans lifted its holdings in Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company's stock valued at $183,541,000 after acquiring an additional 404,811 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Recommended Stories

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines